1. Coccidioidomycosis in the acquired immunodeficiency syndrome.
- Author
-
Bronnimann DA, Adam RD, Galgiani JN, Habib MP, Petersen EA, Porter B, and Bloom JW
- Subjects
- Adult, Amphotericin B therapeutic use, Arizona, Coccidioidomycosis drug therapy, Coccidioidomycosis epidemiology, Humans, Ketoconazole therapeutic use, Lung Diseases, Fungal etiology, Male, Middle Aged, Retrospective Studies, Acquired Immunodeficiency Syndrome complications, Coccidioidomycosis etiology
- Abstract
Of 27 patients with the acquired immunodeficiency syndrome (AIDS) in Tucson, Arizona, 7 had concurrent coccidioidomycosis. Early manifestations of infection in 6 patients included diffuse nodular pulmonary infiltrates and Coccidioides immitis in many extrathoracic sites. By comparison, a retrospective review of the cases of 300 patients hospitalized with coccidioidal infection identified only 13 patients without AIDS who had the same extent of infection, and only 3 of these patients had no immunosuppressing conditions. Antibodies for coccidioidal antigens at serum dilutions as high as 1:2048 were detected in 5 of the 7 patients with AIDS. Six had temporary responses to amphotericin B treatment, taken both alone and combined with ketoconazole, but all died within 14 months of their diagnosis of coccidioidomycosis. Because annual rates of coccidioidal infection in the Tucson area are 4% or less, the rate of 27% that we calculated, based on 7 patients having the infection during 26 years of risk for AIDS, suggests frequent reactivation of the infection or enhanced susceptibility to endemic exposure in persons with AIDS.
- Published
- 1987
- Full Text
- View/download PDF